vTv Therapeutics Inc. (VTVT) Financials

VTVT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 87.6 million 9.0 million
March 31, 2026 98.8 million 8.9 million
Dec. 31, 2025 89.9 million 25.5 million
Sept. 30, 2025 99.5 million 29.0 million

VTVT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -11.4 million 3.1 million
March 31, 2026 9.2 million 1.4 million
Dec. 31, 2025 -9.3 million 1.0 million
Sept. 30, 2025 -5.2 million 1.0 million

VTVT Net Income

No data available :(

VTVT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 86.6 million - -
March 31, 2026 98.1 million - -
Dec. 31, 2025 88.9 million - -
Sept. 30, 2025 98.5 million - 32000

VTVT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 12.4 million
March 31, 2026 8.4 million
Dec. 31, 2025 8.4 million
Sept. 30, 2025 8.1 million

VTVT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 8.8 million 5.2 million -
March 31, 2026 - 9.0 million 4.6 million -
Dec. 31, 2025 - 3.9 million 4.0 million -
Sept. 30, 2025 - 7.0 million 3.7 million -

VTVT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 36.8 million 1000
Dec. 31, 2025 -24000 2000
Sept. 30, 2025 - -

VTVT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

VTVT

Price: $31.48

52 week price:
14.00
44.00

Earnings Per Share: -0.75 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 36900

Ebitda: -11.5 million

Market Capitalization: 118.6 million

Links: